• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES, INC. PERFLUORON; FLUID, INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES, INC. PERFLUORON; FLUID, INTRAOCULAR Back to Search Results
Catalog Number ASKU
Device Problem Insufficient Information (3190)
Patient Problem No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
No data regarding product identity were indicated for the event; therefore, the device history record (dhr) could not be reviewed.No sample was returned; therefore, the condition of the product could not be verified.Because a sample was not returned and no lot number was indicated for this complaint, the root cause cannot be determined.The directions for use (dfu) for this product states: pfo must be completely removed at the conclusion of the procedure by aspiration through either a 23 gauge or flute needle during the air-fluid exchange, or by direct exchange with an appropriate long-term vitreous substitute.Failure to remove may result in visual abnormalities and secondary surgical intervention.(b)(4).
 
Event Description
In a literature article information was presented with regard to a retrospective study of a cluster of six cases of retained intraocular perfluoron (pfo) that occurred after pars plana vitrectomy (ppv) for retinal detachment repair.Pfo was noted in the anterior chamber (ac) and/or vitreous and removed with ac paracentesis, ac wash-out, and/or ppv.These cases were noted shortly after the facility transitioned from non-valved trocar cannulas to valved trocar cannulas between may 16, 2012 through january 7, 2013.This is the fifth of six reports.Reference: oellers p, schneider e, fekrat s, mahmoud t, mruthyunjaya p, hahn p.Retained intraocular perfluoro-n-octane after valved cannula pars plana vitrectomy for retinal detachment.Ophthalmic surg lasers imaging retina.2015; 46: 451-456.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERFLUORON
Type of Device
FLUID, INTRAOCULAR
Manufacturer (Section D)
ALCON LABORATORIES, INC.
6201 south freeway
fort worth TX 76134
Manufacturer (Section G)
ALCON LABORATORIES, INC.
6201 south freeway
fort worth TX 76134
Manufacturer Contact
rita lopez
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8175514846
MDR Report Key5903081
MDR Text Key52948827
Report Number1610287-2016-00094
Device Sequence Number1
Product Code LWL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P950018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Type of Report Initial
Report Date 08/24/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/28/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-